Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to 0.33%.

  • AtriCure's EBITDA Margin rose 60800.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.41%, marking a year-over-year increase of 28300.0%. This contributed to the annual value of 9.62% for FY2024, which is 27700.0% down from last year.
  • Latest data reveals that AtriCure reported EBITDA Margin of 0.33% as of Q3 2025, which was up 60800.0% from 3.83% recorded in Q2 2025.
  • AtriCure's EBITDA Margin's 5-year high stood at 137.64% during Q3 2021, with a 5-year trough of 29.1% in Q1 2021.
  • Its 5-year average for EBITDA Margin is 3.7%, with a median of 8.07% in 2023.
  • As far as peak fluctuations go, AtriCure's EBITDA Margin skyrocketed by 1464000bps in 2021, and later tumbled by -1535300bps in 2022.
  • Over the past 5 years, AtriCure's EBITDA Margin (Quarter) stood at 19.77% in 2021, then skyrocketed by 83bps to 3.38% in 2022, then plummeted by -139bps to 8.07% in 2023, then tumbled by -64bps to 13.24% in 2024, then surged by 98bps to 0.33% in 2025.
  • Its EBITDA Margin stands at 0.33% for Q3 2025, versus 3.83% for Q2 2025 and 4.81% for Q1 2025.